Fund HoldingsCaligan Partners LP

Total Portfolio Value
$515.13M
Total Bought
$81.57M
Total Sold
$48.69M
Net Transaction
+$32.88M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
VERONA PHARMA PLC1,436,8781,436,878091,227135,90026.38%+44,673
MERUS N V376,954656,999+280,04515,86634,5586.71%+18,692
AGIOS PHARMACEUTICALS INC(AGIO)701,2801,071,258+369,97820,54835,6306.92%+15,083
EXELIXIS INC(EXEL)1,525,7301,525,730056,33067,24713.05%+10,917
REVOLUTION MEDICINES INC(RVMD)465,000636,835+171,83516,44223,4294.55%+6,987
REZOLUTE INC141,3091,543,014+1,401,7054106,8821.34%+6,472
SELLAS LIFE SCIENCES GROUP I(SLS)(Call)02,300,000+2,300,00005,037+5,037
ABIVAX SA(ABVX)1,269,1191,674,400+405,2817,93212,8092.49%+4,877
TYRA BIOSCIENCES INC(TYRA)25,000189,950+164,9502331,8180.35%+1,585
AURA BIOSCIENCES INC0200,000+200,00001,2520.24%+1,252
VERRICA PHARMACEUTICALS INC8,992,9549,239,119+246,1653,9774,8980.95%+921
Y-MABS THERAPEUTICS INC2,342,6092,342,609010,37810,5652.05%+187
EVOLUS INC2,731,1543,341,970+610,81632,85630,7805.98%-2,076
ANIKA THERAPEUTICS INC1,435,1301,435,130021,57015,1842.95%-6,386
MINERALYS THERAPEUTICS INC(MLYS)2,149,6672,017,352-132,31534,13727,2955.30%-6,842
BIOCRYST PHARMACEUTICALS INC(BCRX)3,107,669638,908-2,468,76123,3085,7251.11%-17,583
LIQUIDIA CORPORATION(LQDA)8,118,5928,118,892+300119,749101,16119.64%-18,588
SAGE THERAPEUTICS INC3,052,5380-3,052,53824,2680-24,268
Page 1 of 1